07.10.2015
- After a challenging second quarter and first half 2015 – once again marked by foreign exchange turbulence and the impact of acquisitions and divestments – the international...
13.03.2015
- Both European and US pharmaceutical industry players are highly research-oriented and possess very diversified portfolios. While each country has its national champions, Swiss...
30.01.2015
- The European Commission has approved a plan by Novartis and GlaxoSmithKline to swap assets worth more than $20 billion. The proposed deal dates back to April 2014, when Switzerland...
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
09.11.2012
- Swiss drugmaker Novartis's plant in Colorado, has just passed an inspection by U.S. regulators, giving it hope that quality control problems in its North American plants are being...
19.07.2011
- Novartis reported second-quarter net income of $2.73 billion or $1.13 per share versus $2.44 billion or $1.06 per share in the year-ago quarter. Core net income for the quarter...
